We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Screening of antitubercular compound library identifies novel shikimate kinase inhibitors of Mycobacterium tuberculosis.
- Authors
Rajput, Vikrant; Mehra, Rukmankesh; Kumar, Sanjay; Nargotra, Amit; Singh, Parvinder; Khan, Inshad
- Abstract
Shikimate kinase of Mycobacterium tuberculosis is involved in the biosynthesis of aromatic amino acids through shikimate pathway. The enzyme is essential for the survival of M. tuberculosis and is absent from mammals, thus providing an excellent opportunity for identifying new chemical entities to combat tuberculosis with a novel mechanism of action. In this study, an antitubercular library of 1000 compounds was screened against M. tuberculosis shikimate kinase (MtSK). This effort led to the identification of 20 inhibitors, among which five promising leads exhibited half maximal inhibitory concentration (IC) values below 10 μM. The most potent inhibitor ('5631296') showed an IC value of 5.10 μM ± 0.6. The leads were further evaluated for the activity against multidrug-resistant (MDR)-TB, Gram-positive and Gram-negative bacterial strains, mode of action, docking simulations, and combinatorial study with three frontline anti-TB drugs. Compound '5491210' displayed a nearly synergistic activity with rifampicin, isoniazid, and ethambutol while compound '5631296' was synergistic with rifampicin. In vitro cytotoxicity against HepG2 cell line was evaluated and barring one compound; all were found to be non-toxic (SI > 10). In order to rule out mitochondrial toxicity, the promising inhibitors were also evaluated for cell cytotoxicity using galactose medium where compounds '5631296' and '5122752' appeared non-toxic. Upon comprehensive analysis, compound '5631296' was found to be the most promising MtSK inhibitor that was safe, synergistic with rifampicin, and bactericidal against M. tuberculosis.
- Subjects
MYCOBACTERIUM tuberculosis; KINASE inhibitors; BIOCHEMICAL mechanism of action; CELL-mediated cytotoxicity; ANTITUBERCULAR agents; MOLECULAR docking
- Publication
Applied Microbiology & Biotechnology, 2016, Vol 100, Issue 12, p5415
- ISSN
0175-7598
- Publication type
Academic Journal
- DOI
10.1007/s00253-015-7268-8